InsidersTradesSigma
레이언스 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 레이언스 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 레이언스 has logged 6 public disclosures. Market capitalisation: €89.7bn. The latest transaction was filed on 9 March 2026 (Other). Among the most active insiders: 레이언스. Every trade is openly available.
6
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
1 ops.
Sell Volume
Fundamental score
Ranked 18,945 of 27,837 companies
39.9
score / 100
Value48
Quality32
FCF yld7.7%
Earn yld-5.9%
EV/EBITDA·
ROE0.1%
Gross mgn36%
Net mgn-4.6%
Debt/EBITDA3.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 9 March 2026
About 레이언스
레이언스 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions to enhance patient health.